Influence of age, sex and HCMV-serostatus on blood lymphocyte subpopulations in healthy adults

Cellular Immunology

Volumn 314, Issue , 2017, Pages 42-53

  Apoil, P A ^a,b   Puissant Lubrano, B ^a,b   Congy Jolivet, N ^a,b   Peres, M ^b   Tkaczuk, J ^b   Roubinet, F ^c   Blancher, A ^a,b  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Age; Cytomegalovirus; Immunophenotyping; Lymphocyte subpopulations; Reference ranges; Sex

Indexed keywords

CD16 ANTIGEN; CD27 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD56 ANTIGEN; CHEMOKINE RECEPTOR CCR4; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; CD4 ANTIGEN; CD8 ANTIGEN; VIRUS ANTIBODY;

ADULT; AGED; AGING; ARTICLE; B LYMPHOCYTE; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOMEGALOVIRUS INFECTION; EFFECTOR CELL; FEMALE; GROUPS BY AGE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; MALE; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NORMAL HUMAN; PLASMABLAST; PRIORITY JOURNAL; REFERENCE VALUE; REGULATORY T LYMPHOCYTE; SEX DIFFERENCE; AGE; BLOOD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; METABOLISM; MIDDLE AGED; PREVALENCE; T LYMPHOCYTE;

ADULT; AGE FACTORS; AGED; ANTIBODIES, VIRAL; ANTIGENS, CD4; ANTIGENS, CD8; B-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEALTHY VOLUNTEERS; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PREVALENCE; REFERENCE VALUES; SEX FACTORS; T-LYMPHOCYTES;

EID: 85013167913     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2017.02.001     Document Type: Article

References (70)

1. [1] Malaguarnera, L., Ferlito, L., Imbesi, R.M., Gulizia, G.S., Di Mauro, S., Maugeri, D., Malaguarnera, M., Messina, A., Immunosenescence: a review. Arch. Gerontol. Geriatr. 32 (2001), 1–14.
2. [2] Tarazona, R., Solana, R., Ouyang, Q., Pawelec, G., Basic biology and clinical impact of immunosenescence. Exp. Gerontol. 37 (2002), 183–189.
3. [3] Sansoni, P., Vescovini, R., Fagnoni, F., Biasini, C., Zanni, F., Zanlari, L., Telera, A., Lucchini, G., Passeri, G., Monti, D., Franceschi, C., Passeri, M., The immune system in extreme longevity. Exp. Gerontol. 43 (2008), 61–65.
4. [4] Lang, P.O., Mitchell, W.A., Lapenna, A., Pitts, D., Aspinali, R., Immunological pathogenesis of main age-related diseases and frailty: Role of immunosenescence. Eur. Geriatric Med. 1 (2010), 112–121.
5. [5] McCoy, J.P. Jr., Overton, W.R., Quality control in flow cytometry for diagnostic pathology: II. A conspectus of reference ranges for lymphocyte immunophenotyping. Cytometry 18 (1994), 129–139.
6. [6] Clementi, M., Forabosco, P., Amadori, A., Zamarchi, R., De Silvestro, G., Di Gianantonio, E., Chieco-Bianchi, L., Tenconi, R., CD4 and CD8 T lymphocyte inheritance. Evidence for major autosomal recessive genes. Hum. Genet. 105 (1999), 337–342.
7. [7] Evans, D.M., Zhu, G., Duffy, D.L., Frazer, I.H., Montgomery, G.W., Martin, N.G., A major quantitative trait locus for CD4-CD8 ratio is located on chromosome 11. Genes Immun. 5 (2004), 548–552.
8. [8] Brodin, P., Jojic, V., Gao, T., Bhattacharya, S., Angel, C.J., Furman, D., Shen-Orr, S., Dekker, C.L., Swan, G.E., Butte, A.J., Maecker, H.T., Davis, M.M., Variation in the human immune system is largely driven by non-heritable influences. Cell 160 (2014), 37–47.
9. [9] Hall, M.A., Ahmadi, K.R., Norman, P., Snieder, H., MacGregor, A.J., Vaughan, R.W., Spector, T.D., Lanchbury, J.S., Genetic influence on peripheral blood T lymphocyte levels. Genes Immun. 1 (2000), 423–427.
10. [10] Hall, M.A., Norman, P.J., Thiel, B., Tiwari, H., Peiffer, A., Vaughan, R.W., Prescott, S., Leppert, M., Schork, N.J., Lanchbury, J.S., Quantitative trait loci on chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18 control variation in levels of T and B lymphocyte subpopulations. Am. J. Hum. Genet. 70 (2002), 1172–1182.
11. [11] Amadori, A., Zamarchi, R., De Silvestro, G., Forza, G., Cavatton, G., Danieli, G.A., Clementi, M., Chieco-Bianchi, L., Genetic control of the CD4/CD8 T-cell ratio in humans. Nat. Med. 1 (1995), 1279–1283.
12. [12] Libri, V., Azevedo, R.I., Jackson, S.E., Di Mitri, D., Lachmann, R., Fuhrmann, S., Vukmanovic-Stejic, M., Yong, K., Battistini, L., Kern, F., Soares, M.V., Akbar, A.N., Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+CD45RA+CD27+ T cells: the potential involvement interleukin-7 in this process. Immunology 132 (2011), 326–339.
13. [13] Turner, J.E., Campbell, J.P., Edwards, K.M., Howarth, L.J., Pawelec, G., Aldred, S., Moss, P., Drayson, M.T., Burns, V.E., Bosch, J.A., Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive young adults. Age (Dordr) 36 (2014), 287–297.
14. [14] Litjens, N.H., de Wit, E.A., Betjes, M.G., Differential effects of age, cytomegalovirus-seropositivity and end- disease (ESRD) on circulating T lymphocyte subsets. Immun. Ageing, 8, 2011, 2.
15. [15] Sansoni, P., Vescovini, R., Fagnoni, F.F., Akbar, A., Arens, R., Chiu, Y.L., Cicin-Sain, L., Dechanet-Merville, J., Derhovanessian, E., Ferrando-Martinez, S., Franceschi, C., Frasca, D., Fulop, T., Furman, D., Gkrania-Klotsas, E., Goodrum, F., Grubeck-Loebenstein, B., Hurme, M., Kern, F., Lilleri, D., Lopez-Botet, M., Maier, A.B., Marandu, T., Marchant, A., Mathei, C., Moss, P., Muntasell, A., Remmerswaal, E.B., Riddell, N.E., Rothe, K., Sauce, D., Shin, E.C., Simanek, A.M., Smithey, M.J., Soderberg-Naucler, C., Solana, R., Thomas, P.G., van Lier, R., Pawelec, G., Nikolich-Zugich, J., New advances in CMV and immunosenescence. Exp. Gerontol. 55 (2014), 54–62.
16. [16] Nikolich-Zugich, J., Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat. Rev. Immunol. 8 (2008), 512–522.
17. [17] Vescovini, R., Telera, A., Fagnoni, F.F., Biasini, C., Medici, M.C., Valcavi, P., di Pede, P., Lucchini, G., Zanlari, L., Passeri, G., Zanni, F., Chezzi, C., Franceschi, C., Sansoni, P., Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells. Exp. Gerontol. 39 (2004), 1233–1243.
18. [18] Bleakley, M., Heimfeld, S., Jones, L.A., Turtle, C., Krause, D., Riddell, S.R., Shlomchik, W., Engineering human peripheral blood stem cell grafts that are depleted of naive T cells and retain functional pathogen-specific memory T cells. Biol. Blood Marrow Transplant 20 (2014), 705–716.
19. [19] Tchilian, E.Z., Wallace, D.L., Imami, N., Liao, H.X., Burton, C., Gotch, F., Martinson, J., Haynes, B.F., Beverley, P.C., The exon A (C77G) mutation is a common cause of abnormal CD45 splicing in humans. J. Immunol. 166 (2001), 6144–6148.
20. [20] Summers, K.L., O'Donnell, J.L., Hart, D.N., Co-expression of the CD45RA and CD45RO antigens on T lymphocytes in chronic arthritis. Clin. Exp. Immunol. 97 (1994), 39–44.
21. [21] Hamann, D., Baars, P.A., Hooibrink, B., van Lier, R.W., Heterogeneity of the human CD4+ T-cell population: two distinct CD4+ T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms. Blood 88 (1996), 3513–3521.
22. [22] LaSalle, J.M., Hafler, D.A., The coexpression of CD45RA and CD45RO isoforms on T cells during the S/G2/M stages of cell cycle. Cell. Immunol. 138 (1991), 197–206.
23. [23] Horowitz, G., Altaie, S., Boyd, J., Ceriotti, F., Garg, U., Hom, P., Pesce, A., Sine, H., Zakowski, J., Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline—Third Edition, EP28A3E. 2010, CLSI, Clinical and Laboratory Standards Institute.
24. [24] Geffre, A., Concordet, D., Braun, J.P., Trumel, C., Reference Value Advisor: a new freeware set of macroinstructions to calculate reference intervals with Microsoft Excel. Vet. Clin. Pathol. 40 (2011), 107–112.
25. [25] Tukey, J., Exploratory Data Analysis. 1977, Addison-Wesley.
26. [26] P.A. Apoil, B. Puissant-Lubrano, N. Congy-Jolivet, M. Peres, J. Tkaczuk, F. Roubinet, A. Blancher, Reference values for T, B and NK human lymphocyte subpopulations in adults., Data in Brief, (in press).
27. [27] Bisset, L.R., Lung, T.L., Kaelin, M., Ludwig, E., Dubs, R.W., Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland. Eur. J. Haematol. 72 (2004), 203–212.
28. [28] Guma, M., Angulo, A., Vilches, C., Gomez-Lozano, N., Malats, N., Lopez-Botet, M., Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104 (2004), 3664–3671.
29. [29] Della Chiesa, M., Pesce, S., Muccio, L., Carlomagno, S., Sivori, S., Moretta, A., Marcenaro, E., Features of memory-like and PD-1(+) human NK cell subsets. Front. Immunol., 7, 2016, 351.
30. [30] Almehmadi, M., Flanagan, B.F., Khan, N., Alomar, S., Christmas, S.E., Increased numbers and functional activity of CD56(+) T cells in healthy cytomegalovirus positive subjects. Immunology 142 (2014), 258–268.
31. [31] Gumperz, J.E., Valiante, N.M., Parham, P., Lanier, L.L., Tyan, D., Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype. J. Exp. Med. 183 (1996), 1817–1827.
32. [32] Zloza, A., Al-Harthi, L., Multiple populations of T lymphocytes are distinguished by the level of CD4 and CD8 coexpression and require individual consideration. J. Leukoc. Biol. 79 (2006), 4–6.
33. [33] Parel, Y., Chizzolini, C., CD4+ CD8+ double positive (DP) T cells in health and disease. Autoimmun. Rev. 3 (2004), 215–220.
34. [34] Suni, M.A., Ghanekar, S.A., Houck, D.W., Maecker, H.T., Wormsley, S.B., Picker, L.J., Moss, R.B., Maino, V.C., CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens. Eur. J. Immunol. 31 (2001), 2512–2520.
35. [35] Lambert, C., Genin, C., CD3 bright lymphocyte population reveal gammadelta T cells. Cytometry B Clin. Cytom. 61 (2004), 45–53.
36. [36] Trautmann, A., Ruckert, B., Schmid-Grendelmeier, P., Niederer, E., Brocker, E.B., Blaser, K., Akdis, C.A., Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic/effector subpopulation. Immunology 108 (2003), 305–312.
37. [37] Lin, X., Chen, M., Liu, Y., Guo, Z., He, X., Brand, D., Zheng, S.G., Advances in distinguishing natural from induced Foxp3(+) regulatory T cells. Int. J. Clin. Exp. Pathol. 6 (2013), 116–123.
38. [38] Baecher-Allan, C., Wolf, E., Hafler, D.A., MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 176 (2006), 4622–4631.
39. [39] Vukmanovic-Stejic, M., Zhang, Y., Cook, J.E., Fletcher, J.M., McQuaid, A., Masters, J.E., Rustin, M.H., Taams, L.S., Beverley, P.C., Macallan, D.C., Akbar, A.N., Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 116 (2006), 2423–2433.
40. [40] Derhovanessian, E., Chen, S., Maier, A.B., Hahnel, K., de Craen, A.J., Roelofs, H., Westendorp, R., Pawelec, G., CCR4+ regulatory T cells accumulate in the very elderly and correlate with superior 8-year survival. J. Gerontol. A Biol. Sci. Med. Sci. 70 (2015), 917–923.
41. [41] Shipkova, M., Wieland, E., Surface markers of lymphocyte activation and markers of cell proliferation. Clin. Chim. Acta 413 (2012), 1338–1349.
42. [42] Holling, T.M., Schooten, E., van Den Elsen, P.J., Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men. Hum. Immunol. 65 (2004), 282–290.
43. [43] Franceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., Panourgia, M.P., Invidia, L., Celani, L., Scurti, M., Cevenini, E., Castellani, G.C., Salvioli, S., Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128 (2007), 92–105.
44. [44] Crough, T., Khanna, R., Immunobiology of human cytomegalovirus: from bench to bedside. Clin. Microbiol. Rev. 22 (2009), 76–98 Table of Contents.
45. [45] Zanghellini, F., Boppana, S.B., Emery, V.C., Griffiths, P.D., Pass, R.F., Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J. Infect. Dis. 180 (1999), 702–707.
46. [46] Varani, S., Landini, M.P., Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae, 2, 2011, 6.
47. [47] Li, H., Weng, P., Najarro, K., Xue, Q.L., Semba, R.D., Margolick, J.B., Leng, S.X., Chronic CMV infection in older women: longitudinal comparisons of CMV DNA in peripheral monocytes, anti-CMV IgG titers, serum IL-6 levels, and CMV pp65 (NLV)-specific CD8(+) T-cell frequencies with twelve year follow-up. Exp. Gerontol. 54 (2014), 84–89.
48. [48] Stowe, R.P., Kozlova, E.V., Yetman, D.L., Walling, D.M., Goodwin, J.S., Glaser, R., Chronic herpesvirus reactivation occurs in aging. Exp. Gerontol. 42 (2007), 563–570.
49. [49] Solana, R., Tarazona, R., Aiello, A.E., Akbar, A.N., Appay, V., Beswick, M., Bosch, J.A., Campos, C., Cantisan, S., Cicin-Sain, L., Derhovanessian, E., Ferrando-Martinez, S., Frasca, D., Fulop, T., Govind, S., Grubeck-Loebenstein, B., Hill, A., Hurme, M., Kern, F., Larbi, A., Lopez-Botet, M., Maier, A.B., McElhaney, J.E., Moss, P., Naumova, E., Nikolich-Zugich, J., Pera, A., Rector, J.L., Riddell, N., Sanchez-Correa, B., Sansoni, P., Sauce, D., van Lier, R., Wang, G.C., Wills, M.R., Zielinski, M., Pawelec, G., CMV and immunosenescence: from basics to clinics. Immun. Ageing, 9, 2012, 23.
50. [50] Romero, P., Zippelius, A., Kurth, I., Pittet, M.J., Touvrey, C., Iancu, E.M., Corthesy, P., Devevre, E., Speiser, D.E., Rufer, N., Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J. Immunol. 178 (2007), 4112–4119.
51. [51] Sathaliyawala, T., Kubota, M., Yudanin, N., Turner, D., Camp, P., Thome, J.J., Bickham, K.L., Lerner, H., Goldstein, M., Sykes, M., Kato, T., Farber, D.L., Distribution and compartmentalization of human circulating and memory T cell subsets. Immunity 38 (2012), 187–197.
52. [52] Farber, D.L., Yudanin, N.A., Restifo, N.P., Human memory T cells: generation, compartmentalization and homeostasis. Nat. Rev. Immunol. 14 (2014), 24–35.
53. [53] Larbi, A., Fulop, T., From “truly naive” to “exhausted senescent” T cells: when markers predict functionality. Cytometry A 85 (2014), 25–35.
54. [54] Appay, V., van Lier, R.A., Sallusto, F., Roederer, M., Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 73 (2008), 975–983.
55. [55] Savva, G.M., Pachnio, A., Kaul, B., Morgan, K., Huppert, F.A., Brayne, C., Moss, P.A., Cytomegalovirus infection is associated with increased mortality in population. Aging Cell 12 (2013), 381–387.
56. [56] Simanek, A.M., Dowd, J.B., Pawelec, G., Melzer, D., Dutta, A., Aiello, A.E., Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS ONE, 6, 2011, e16103.
57. [57] Mortensen, L.H., Maier, A.B., Slagbom, P.E., Pawelec, G., Derhovanessian, E., Petersen, I., Jahn, G., Westendorp, R.G., Christensen, K., Early-life environment influencing susceptibility to cytomegalovirus infection: evidence from the Leiden Longevity Study and the Longitudinal Study of Aging Danish Twins. Epidemiol. Infect. 140 (2012), 835–841.
58. [58] Hecker, M., Qiu, D., Marquardt, K., Bein, G., Hackstein, H., Continuous cytomegalovirus seroconversion in a large group of healthy donors. Vox Sang. 86 (2004), 41–44.
59. [59] Colugnati, F.A., Staras, S.A., Dollard, S.C., Cannon, M.J., Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect. Dis., 7, 2007, 71.
60. [60] Wertheimer, A.M., Bennett, M.S., Park, B., Uhrlaub, J.L., Martinez, C., Pulko, V., Currier, N.L., Nikolich-Zugich, D., Kaye, J., Nikolich-Zugich, J., Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J. Immunol. 192 (2014), 2143–2155.
61. [61] Pandya, J.M., Venalis, P., Al-Khalili, L., Hossain, M.S., Stache, V., Lundberg, I.E., Malmstrom, V., Fasth, A.E., CD4+ and CD8+ CD28null T cells are cytotoxic to autologous muscle cells in polymyositis patients. Arthritis Rheumatol., 2016.
62. [62] Soderberg-Naucler, C., HCMV microinfections in inflammatory diseases and cancer. J. Clin. Virol. 41 (2008), 218–223.
63. [63] Fasth, A.E., Cao, D., van Vollenhoven, R., Trollmo, C., Malmstrom, V., CD28nullCD4+ T cells–characterization of an effector memory T-cell population in patients with rheumatoid arthritis. Scand. J. Immunol. 60 (2004), 199–208.
64. [64] Aslan, N., Yurdaydin, C., Wiegand, J., Greten, T., Ciner, A., Meyer, M.F., Heiken, H., Kuhlmann, B., Kaiser, T., Bozkaya, H., Tillmann, H.L., Bozdayi, A.M., Manns, M.P., Wedemeyer, H., Cytotoxic CD4 T cells in viral hepatitis. J. Viral Hepat. 13 (2006), 505–514.
65. [65] Meijers, R.W., Litjens, N.H., Hesselink, D.A., Langerak, A.W., Baan, C.C., Betjes, M.G., Primary cytomegalovirus infection significantly impacts circulating T cells in kidney transplant recipients. Am. J. Transplant. 15 (2015), 3143–3156.
66. [66] Vliegen, I., Herngreen, S.B., Grauls, G.E., Bruggeman, C.A., Stassen, F.R., Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice. Atherosclerosis 181 (2005), 39–44.
67. [67] Hegde, N.R., Dunn, C., Lewinsohn, D.M., Jarvis, M.A., Nelson, J.A., Johnson, D.C., Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL. J. Exp. Med. 202 (2005), 1109–1119.
68. [68] van Leeuwen, E.M., Remmerswaal, E.B., Vossen, M.T., Rowshani, A.T., Wertheim-van Dillen, P.M., van Lier, R.A., ten Berge, I.J., Emergence of a CD4+CD28− granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J. Immunol. 173 (2004), 1834–1841.
69. [69] Lugthart, G., van Ostaijen-Ten Dam, M.M., Jol-van der Zijde, C.M., van Holten, T.C., Kester, M.G., Heemskerk, M.H., Bredius, R.G., van Tol, M.J., Lankester, A.C., Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant 20 (2014), 655–661.
70. [70] Di Mitri, D., Azevedo, R.I., Henson, S.M., Libri, V., Riddell, N.E., Macaulay, R., Kipling, D., Soares, M.V., Battistini, L., Akbar, A.N., Reversible senescence in human CD4+CD45RA+CD27− memory T cells. J. Immunol. 187 (2011), 2093–2100.